ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Analysts Cool on GE, Warm to Defence Names

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

General Electric saw the week's sharpest consensus target cut. The average analyst price target slipped to $378.43, down from $378.90, as one analyst trimmed their call. The consensus still skews bullish, with 20 buy-equivalent ratings against just one sell.

Defence peers moved the other way. Lockheed Martin and Northrop Grumman both received upward target revisions, taking consensus targets to $636 and $632 respectively. The sector continues to attract positive analyst attention amid elevated global spending.

Moderna earned the most notable upward target lift of the session. The consensus price target rose to $138.37, a clear step up from $135.84. Sentiment is mixed, with 15 hold-equivalent ratings flanked by three buys and four sells.

McCormick faces pressure from two fronts. Analysts cut their average target to $54.46 from $54.85. ORTEX Index Rebalance Radar puts the spice maker at 82% probability of deletion from the MSCI World in the November review, with $726M of potential forced selling. That combination of softer analyst sentiment and looming index outflows is worth watching.

Deckers Outdoor also attracted a target reduction, to $98.19 from $99.95. The footwear group carries four sell-equivalent ratings, the most bearish skew in today's changes.

Bloom Energy saw multiple simultaneous changes. The consensus target edged up to $284.77, but one analyst shifted from a buy-equivalent to a hold, narrowing the bullish camp.

Stocks in this article

How this article was generated

Generated
26 Oct 2026, 08:20
Prompt version
v1.0
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.